Mohamed Hassan | Medicine and Health Sciences | Best Researcher Award

Published on 15/03/202515/03/2025 by Research Hypothesis

Mohamed Hassan | Medicine and Health Sciences | Best Researcher Award

Assist. Prof. Dr Mohamed Hassan, Tulane University School of Medicine, United States

Assist. Prof. Dr. Mohamed Hassan is a distinguished researcher in molecular biology, tumor biology, and virology 🧬. His groundbreaking work focuses on tumor progression, cancer stem cell biology, and innovative therapeutic strategies 🎯. With an extensive portfolio of high-impact publications 📄 and supervised doctoral candidates 🎓, his research significantly contributes to understanding melanoma resistance, non-receptor tyrosine kinases, and immune checkpoint inhibitors 🏥. He has collaborated with leading international institutions, enriching the field with novel discoveries in oncology 🔬. His contributions extend beyond research, fostering the next generation of scientists and improving clinical oncology outcomes 🏥.

Publication Profile

Orcid

Education

Dr. Mohamed Hassan earned his Ph.D. in Molecular Biology 🏅 from the University Hospital of Düsseldorf, Germany (2001), where his research focused on the interference of the Hepatitis C Virus (HCV) core protein with intracellular signal transduction in liver cells 🦠. He holds an M.Sc. in Molecular Biology 📖 from the University of Düsseldorf (1996), with a thesis on identifying and characterizing differentially expressed cDNA libraries in Plasmodium malaria chabaudi immune mice 🧪. His academic journey began with a B.Sc. in Biological Sciences 🏫 from Zagazig University, Egypt, and the University of Düsseldorf (1983). His expertise in cancer biology, virology, and molecular research 📊 has established him as a leading researcher in the field.

Experience

Assist. Prof. Dr. Mohamed Hassan is a dedicated cancer researcher with extensive expertise in tumor progression, oncological drug resistance, and precision medicine 🔬💊. He is currently a Senior Postdoctoral Fellow at the Institut National de la Santé et de la Recherche Médicale, University of Strasbourg, France (2018-2025) 🏥. Previously, he served as a Research Assistant Professor at Tulane University School of Medicine, USA (2016-2018) 🎓, and a Postdoctoral Fellow at the University Hospital of Düsseldorf, Germany (2002-2004). His groundbreaking work focuses on identifying biomarkers and developing targeted therapies to enhance cancer treatment worldwide 🌍🧬.

Research Focus

Assist. Prof. Dr. Mohamed Hassan’s research focuses on tumor progression, cancer stem-like cells, and treatment resistance 🧬. His work delves into melanoma’s resistance to standard therapies 🎯, mechanisms of tumor progression and immune evasion 🏥, and targeting cancer stem-like cells to enhance treatment efficacy 💊. He investigates the role of non-receptor tyrosine kinases in oncogenesis 🔬 and explores immune checkpoint inhibitors and their associated cutaneous adverse effects ⚕️. Additionally, his discovery of antimicrobial peptides holds promise for clinical applications 🦠. His contributions drive novel therapeutic strategies, improving cancer treatment outcomes worldwide 🌍.

Publication Top Notes

Reduction of Prostate Cancer Risk: Role of Frequent Ejaculation-Associated Mechanisms

Immune Checkpoint Inhibitor-Associated Cutaneous Adverse Events: Mechanisms of Occurrence

Non-Receptor Tyrosine Kinases: Their Structure and Mechanistic Role in Tumor Progression and Resistance

<i>hTERT</i> Epigenetics Provides New Perspectives for Diagnosis and Evidence-Based Guidance of Chemotherapy in Cancer

CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance

Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells

Induction of Antimicrobial Protein S100A15 Expression by Oral Microbial Pathogens Is Toll-like Receptors-Dependent Activation of c-Jun-N-Terminal Kinase (JNK), p38, and NF-κB Pathways

GORDON WEST | Medicine and Health Sciences | Best Researcher Award

Published on 24/02/202524/02/2025 by Research Hypothesis

GORDON WEST | Medicine and Health Sciences | Best Researcher Award

Dr GORDON WEST, Pacific Lutheran University School of Nursing – Tacoma, WA, United States

Dr. Gordon West is a dedicated nurse scientist and healthcare leader with a PhD from the Uniformed Services University (2016) 🎓. He holds an MHA from Baylor University (2006) and a BSN from McMurry University (1998) 🏥. Currently, he is a Research Nurse at The Geneva Foundation-Madigan and an Assistant Professor at Pacific Lutheran University 📚. With vast experience in military and civilian healthcare, he has led numerous research projects on infection control, patient safety, and military health 🩺. A Fellow of the American College of Healthcare Executives, he has received multiple awards for nursing research and excellence 🏆.

Publication Profile

Google Scholar

Education

Dr. Gordon West 🎓 is a dedicated healthcare professional with a strong academic background. He earned his Ph.D. in 2016 from the Uniformed Services University of the Health Sciences 🏥 in Bethesda, MD. Prior to that, he completed his Master of Healthcare Administration (MHA) in 2006 at Baylor University 🏛️ in Fort Sam Houston. His journey in healthcare began with a Bachelor of Science in Nursing (BSN) from McMurry University 🎓 in Abilene, TX, in 1998. With extensive education and expertise, Dr. West continues to contribute to the field of healthcare and administration with passion and dedication. 💉📚

Experience

Dr. Gordon West is a dedicated Research Nurse 🩺 at The Geneva Foundation – Madigan (2023-present) and an Assistant Professor 📚 at Pacific Lutheran University (2022-present). He actively contributes as a Research Board Member at the Washington State Nursing Association & Health Care Council and a Board Member at Rainer Olympic Nurses Association. His extensive military nursing career includes leadership roles at Madigan AMC, Tripler, and Fort Belvoir 🏥, alongside international service in Korea 🇰🇷 and Iraq 🇮🇶. A Ph.D. graduate from USUHS 🎓, he also teaches at Maryville University and Central Michigan University, shaping future nursing professionals. 🌟

Awards & Honors

Dr. Gordon West has been recognized for his outstanding contributions to nursing and healthcare research 🏥📚. In 2023, he received a Daisy Nomination from Pacific Lutheran University for his dedication to patient care and nursing excellence 🌿🏆. In 2019, he was honored with the ANCA Nursing Research Award by the Army Nurse Corps Association, highlighting his impactful research in military nursing 🎖️🔬. That same year, he also received the Excellence in Nursing Research Award from the Defense Health Agency, acknowledging his commitment to advancing healthcare through evidence-based practices and innovation 🏅💡.

Research Focus

Dr. Gordon B. West’s research explores critical language pedagogy 🎓📖, focusing on morality, identity, and power in neoliberal English language education 🌍💬. His work critically examines good teacher identities in South Korea 🇰🇷, the politicization of language educators 🗣️⚖️, and the emotional complexities of critical pedagogy ❤️🧠. He also investigates sociohistorical perspectives on literacy 📚⏳ and the challenges of critical practitioner research under difficult conditions 🔍🛠️. Through qualitative and materialist approaches, Dr. West sheds light on language education as both a tool for liberation and oppression ✊🔗, emphasizing the impact of neoliberalism on English teaching 💵🏫.

Presentation

Dr. Gordon West is a dedicated nursing researcher focusing on infection control 🦠, patient safety 🏥, and healthcare communication 📢. He has presented extensively, including at the Phyllis J. Verhonick Conference (2016) on patient education and fall prevention 🩺. His work on bacterial contamination of hospital uniforms led to multiple presentations at the American Organization of Nurse Executives Conference (2016-2017) and the Sigma 29th International Nursing Research Conference in Melbourne (2018) 🌏. He also explored hands-free communication in nursing at TSNRP (2017). His research enhances clinical safety, infection prevention, and nurse satisfaction, shaping better healthcare practices globally 🌍.

Publication Top Notes

Navigating morality in neoliberal spaces of English language education

Young learners’ portrayals of ‘good English teacher’identities in South Korea

Critical practitioner research in language education under difficult circumstances

“How did you become political?”: Narratives of junior researcher-practitioners in applied linguistics

“Is this a safe space?”: Examining an emotionally charged eruption in critical language pedagogy

Literacy is a Sociohistoric Phenomenon with the Potential to Liberate and Oppress

Doing critical language pedagogy in neoliberal spaces: A materialist narrative analysis of teaching young learners of English in a Korean hagwon

Positioning of female marriage immigrants in South Korea: a multimodal textbook analysis

Alfonso Luca Pendolino | Medicine and Health Sciences | Best Researcher Award

Published on 21/09/202421/09/2024 by Research Hypothesis

Alfonso Luca Pendolino | Medicine and Health Sciences | Best Researcher Award

Mr Alfonso Luca Pendolino, University College London, United Kingdom

Based on Mr. Alfonso Luca Pendolino’s experience and research, he could be considered a strong candidate for the Best Researcher Award. Here’s why:

Publication profile

Scopus

Education

From October 2021, a part-time PhD student at UCL’s Ear Institute focused on olfactory dysfunction in chronic respiratory diseases. Clinical Fellow at the Royal National Throat, Nose & Ear Hospital, London. Delivered oral presentations at ERS Thessaloniki 2021 on nasal septal perforation repair and the triple-layer technique. Earned a diploma in Otorhinolaryngology from the University of Padova with magna cum laude honors. Actively engaged in various courses, including Balloon Sinuplasty in Guildford and Smell and Taste 11 in Dresden. Member of ENT UK and the British Rhinological Society, with scientific habilitation in Italy. ✨👃📚💼

Experience

From October 2023 to October 2024, the user works as a Senior Clinical Fellow at St George’s University Hospital NHS Foundation Trust in Ear, Nose, and Throat Surgery, focusing on rhinology and anterior skull base procedures. From February 2019 to October 2023, they held a similar role at the Royal National Throat, Nose and Ear Hospital, part of University College London Hospitals. Since October 2019, they have also been pursuing a PhD in the Ear Institute at University College London, focusing on research. Previously, from December 2014 to December 2018, they trained as a resident in Otolaryngology at the University of Padova. 🎓🩺📊

Expertise and Contributions

Mr. Pendolino has extensive clinical and academic experience in Ear, Nose, and Throat (ENT) surgery, particularly in rhinology and anterior skull base procedures. His work spans senior clinical fellowships at prestigious institutions like St. George’s University Hospital and the Royal National Throat, Nose, and Ear Hospital, combined with a PhD research focus on olfactory dysfunction at the University College London (UCL). This academic engagement showcases his commitment to advancing medical science, specifically in rhinology.

Notable Research and Publications

He has contributed significantly to academic research, authoring several impactful papers on topics such as nasal septal perforation repair, cocaine-induced destructive lesions, and smell loss related to COVID-19. His recent publications in high-impact journals such as Diagnostics and Laryngoscope address both clinical outcomes and advanced ENT techniques, demonstrating a broad impact on both scientific understanding and patient care.

Continuous Learning and Development

Throughout his career, Mr. Pendolino has pursued a range of certifications and courses, from endoscopic skull base surgery to rhinoplasty, which highlights his dedication to continual professional development. His involvement in international conferences, including oral communications and workshops, further positions him as a leader in his field.

Research Impact

Although many of his papers have limited citations due to their recent publication, his research has already influenced surgical practices and patient outcomes, especially concerning sinus surgery and chronic respiratory disease management.

conclusion

Mr. Pendolino’s combination of clinical expertise, high-quality research, and ongoing contributions to ENT surgery make him a commendable candidate for the Best Researcher Award.

Publication top notes

Objective and Subjective Outcomes Following Radiofrequency of Inferior Turbinates in Patients with Sleep-Disordered Breathing

The role of ANCA in the management of cocaine-induced midline destructive lesions or ENT pseudo-granulomatosis with polyangiitis: a London multicentre case series

Quality of Life in NSAIDs-Exacerbated Respiratory Disease on or off Intranasal Lysine Aspirin Therapy

Clinical factors influencing olfactory performance in patients with persistent COVID-19 smell loss longer than 1 year

The role of large cavity sinus surgery in the management of chronic rhinosinusitis in non-steroidal anti-inflammatory drug exacerbated respiratory disease: A single-centre experience and long-term outcomes

Reply to: Letter to the editor regarding “Long-term quality-of-life impairment in patients with more than 1-year COVID-19–related olfactory dysfunction”

Emmanouil Dermitzakis | Medicine and Health Sciences | Best Researcher Award

Published on 16/09/202416/09/2024 by Research Hypothesis

Emmanouil Dermitzakis | Medicine and Health Sciences | Best Researcher Award

Dr Emmanouil Dermitzakis, Euromedica General Clinic, Greece

Dr. Emmanouil Dermitzakis appears to be a strong candidate for the Best Researcher Award based on the following criteria:

Publication profile

google scholar

Qualifications & Experience

Extensive Training and Certification: Dr. Dermitzakis has undergone comprehensive training in Internal Medicine, Psychiatry, and Neurology, with board certification in Neurology.

Diverse Clinical Experience: He has worked in various roles, including as a research fellow, neurologist in multiple settings, and medical advisor. His roles have spanned private practice, academic institutions, and specialized clinics.

Research Contributions

Clinical Trials & Studies: Dr. Dermitzakis has been involved as both a Sub-Investigator and Principal Investigator in numerous significant clinical trials, such as the ECASS 3 trial and various migraine-related studies. His research includes evaluating new treatments and methodologies for migraine and headache disorders.

Published Works: He has published numerous articles in reputable journals, covering a wide range of topics from headache management to the effects of chemotherapy on the autonomic nervous system. His work includes research on migraine treatments, including botulinum toxin and novel therapies.

Editorial and Advisory Roles

Guest Editor: He has served as a Guest Editor for a special issue on headache disorders, reflecting his expertise and leadership in the field.

Medical Advisory Roles: As a medical advisor for the Hellenic Society of Migraine and Headache Patients, Dr. Dermitzakis contributes to advancing treatment strategies and improving patient care.

Notable Publications

His research includes impactful studies such as the evaluation of onabotulinumtoxinA in chronic migraine treatment, and the effects of chemotherapy on the autonomic nervous system. These contributions have been published in high-impact journals like The Journal of Headache and Pain and BMC Neurology.

Conclusion

Dr. Dermitzakis’s combination of clinical expertise, substantial research experience, leadership in neurology and headache management, and influential publications make him a notable candidate for the Best Researcher Award. His ongoing contributions to neurology and headache research demonstrate a commitment to advancing medical knowledge and improving patient outcomes.

Publication top notes

Patients’ preferences for headache acute and preventive treatment

Clinical experience with transcutaneous supraorbital nerve stimulation in patients with refractory migraine or with migraine and intolerance to topiramate: a prospective …

Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment

Onabotulinumtoxin-A treatment in Greek patients with chronic migraine

The impact of paclitaxel and carboplatin chemotherapy on the autonomous nervous system of patients with ovarian cancer

Headache patients in the emergency department of a Greek tertiary care hospital

OnabotulinumtoxinA add-on to monoclonal anti-CGRP antibodies in treatment-refractory chronic migraine

Open label prospective experience of supplementation with a fixed combination of magnesium, vitamin B2, feverfew, andrographis paniculata and coenzyme Q10 for episodic migraine …

Long‐term adherence, safety, and efficacy of repeated onabotulinumtoxinA over five years in chronic migraine prophylaxis

Efficacy and safety of fremanezumab for migraine prophylaxis in patients with at least three previous preventive failures: prospective, multicenter, real‐world data from a …

Ahmed Ali | Medicine and Health Sciences | Best Researcher Award

Published on 31/07/202431/07/2024 by Research Hypothesis

Ahmed Ali | Medicine and Health Sciences | Best Researcher Award

Dr Ahmed Ali, Beni-Suef University, Egypt

Based on Dr. Ahmed Ali’s extensive background in veterinary medicine, his significant contributions to vaccine development, and his active research in poultry diseases and vaccine efficacy, he appears to be a strong candidate for the Research for Best Researcher Award.

Publication profile

google scholar

Education and Training

Dr. Ali holds advanced degrees in Veterinary Medicine and Poultry Diseases from Beni-Suef University and The Ohio State University, showcasing a solid educational foundation in his field.

Research Contributions

His work includes leading the development of reverse genetics vaccines for avian influenza and Newcastle disease, and his involvement in live attenuated and inactivated vaccine research. This demonstrates a high level of expertise and impact in vaccine research and development.

Professional Experience

Dr. Ali has held various positions, from demonstrator to technical manager, and has been involved in significant roles related to vaccine R&D and quality control at MEVAC and the National Veterinary Vaccine Co. His roles highlight a career dedicated to advancing vaccine technologies and ensuring their quality and safety.

Publications

He has authored numerous research articles on vaccine safety, efficacy, and development, contributing valuable knowledge to the field. His research is published in reputable journals, reflecting the quality and relevance of his work.

Certifications and Skills

Dr. Ali’s certifications in biorisk management, strategic planning, and Six Sigma further demonstrate his commitment to excellence and continuous improvement in his field.

Field Achievements

His leadership in developing innovative vaccines and ensuring compliance with international standards underscores his significant contributions to veterinary science.